Industry Roundup: Mannatech, FTC On Lunada, Nutroganics, Vitamin Shoppe
This article was originally published in The Tan Sheet
Executive Summary
Mannatech rides Asia-Pacific growth; FTC disputes Lunada claims; Nutroganics sprouts profit; Vitamin Shoppe calms Oregon, Vermont on BMPEA; and more news in brief.
You may also be interested in...
In Brief
Appropriations subcommittee largely ignores FDA; analysts predict lower Novartis OTC sales; France tightens advertising rules; NAD weighs in on Lunada claims; Global Biotechnologies supplements seized; Tetley tea faces lawsuit for antioxidant claims; more news In Brief.
Merck KGaA's Diversified Business Model Proves Its Worth During Pandemic
Germany’s Merck KGaA rapidly expanded its life sciences services business to support the manufacture of COVID-19 vaccines during 2020, and also expects cancer and multiple sclerosis products to fuel its sales growth in coming years.
UCB Aims To Tailor Myasthenia Gravis Therapy Options To Patients
Belgium’s UCB Pharma is expecting progress with new candidates for myasthenia gravis, psoriasis and osteoporosis this year.
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: